TickerFacts.

Cell Source, Inc. (CLCS): Cash & Equivalents

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2013-12-31, 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2024-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$222.7K
As of 2022-12-31
$371.0K2012-12-31: $22.1K2013-12-31: $28.9K2014-12-31: $19.5K2015-12-31: $6.9K2016-12-31: $3.7K2017-12-31: $371.0K2018-12-31: $18.9K2019-12-31: $27.9K2020-12-31: $241.6K2021-12-31: $93.1K2022-12-31: $222.7K$222.7K
2012-12-31 Cash & Equivalents (USD) 2022-12-31
Period endedCash & EquivalentsChange YoYSource filing
2022-12-31$222.7K+139.2%2023-08-08, Balance as of period end
2021-12-31$93.1K-61.5%2023-08-08, Balance as of period end
2020-12-31$241.6Kn/c2022-04-15, Balance as of period end
2019-12-31$27.9K+47.4%2021-04-15, Balance as of period end
2018-12-31$18.9K-94.9%2020-03-30, Balance as of period end
2017-12-31$371.0Kn/m2019-04-01, Balance as of period end
2016-12-31$3.7K-46.2%2018-07-25, Balance as of period end
2015-12-31$6.9K-64.4%2018-07-25, Balance as of period end
2014-12-31$19.5K-32.5%2016-04-14, Balance as of period end
2013-12-31$28.9Kn/c2015-03-13, Balance as of period end
2012-12-31$22.1Kn/a2014-03-25, Balance as of period end